Literature DB >> 26250685

TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD.

Jonathan P Ling1, Olga Pletnikova1, Juan C Troncoso2, Philip C Wong3.   

Abstract

Cytoplasmic aggregation of TDP-43, accompanied by its nuclear clearance, is a key common pathological hallmark of amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD). However, a limited understanding of this RNA-binding protein (RBP) impedes the clarification of pathogenic mechanisms underlying TDP-43 proteinopathy. In contrast to RBPs that regulate splicing of conserved exons, we found that TDP-43 repressed the splicing of nonconserved cryptic exons, maintaining intron integrity. When TDP-43 was depleted from mouse embryonic stem cells, these cryptic exons were spliced into messenger RNAs, often disrupting their translation and promoting nonsense-mediated decay. Moreover, enforced repression of cryptic exons prevented cell death in TDP-43-deficient cells. Furthermore, repression of cryptic exons was impaired in ALS-FTD cases, suggesting that this splicing defect could potentially underlie TDP-43 proteinopathy.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26250685      PMCID: PMC4825810          DOI: 10.1126/science.aab0983

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  27 in total

Review 1.  Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration.

Authors:  Edward B Lee; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2011-11-30       Impact factor: 34.870

2.  Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis.

Authors:  Brian C Kraemer; Theresa Schuck; Jeanna M Wheeler; Linda C Robinson; John Q Trojanowski; Virginia M Y Lee; Gerard D Schellenberg
Journal:  Acta Neuropathol       Date:  2010-03-03       Impact factor: 17.088

3.  Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism.

Authors:  Po-Min Chiang; Jonathan Ling; Yun Ha Jeong; Donald L Price; Susan M Aja; Philip C Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

4.  Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43.

Authors:  Magdalini Polymenidou; Clotilde Lagier-Tourenne; Kasey R Hutt; Stephanie C Huelga; Jacqueline Moran; Tiffany Y Liang; Shuo-Chien Ling; Eveline Sun; Edward Wancewicz; Curt Mazur; Holly Kordasiewicz; Yalda Sedaghat; John Paul Donohue; Lily Shiue; C Frank Bennett; Gene W Yeo; Don W Cleveland
Journal:  Nat Neurosci       Date:  2011-02-27       Impact factor: 24.884

5.  Characterizing the RNA targets and position-dependent splicing regulation by TDP-43.

Authors:  James R Tollervey; Tomaž Curk; Boris Rogelj; Michael Briese; Matteo Cereda; Melis Kayikci; Julian König; Tibor Hortobágyi; Agnes L Nishimura; Vera Zupunski; Rickie Patani; Siddharthan Chandran; Gregor Rot; Blaž Zupan; Christopher E Shaw; Jernej Ule
Journal:  Nat Neurosci       Date:  2011-02-27       Impact factor: 24.884

6.  TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis.

Authors:  Edor Kabashi; Paul N Valdmanis; Patrick Dion; Dan Spiegelman; Brendan J McConkey; Christine Vande Velde; Jean-Pierre Bouchard; Lucette Lacomblez; Ksenia Pochigaeva; Francois Salachas; Pierre-Francois Pradat; William Camu; Vincent Meininger; Nicolas Dupre; Guy A Rouleau
Journal:  Nat Genet       Date:  2008-03-30       Impact factor: 38.330

7.  TDP-43 is a developmentally regulated protein essential for early embryonic development.

Authors:  Chantelle F Sephton; Shannon K Good; Stan Atkin; Colleen M Dewey; Paul Mayer; Joachim Herz; Gang Yu
Journal:  J Biol Chem       Date:  2009-12-29       Impact factor: 5.157

8.  TDP-43 regulates its mRNA levels through a negative feedback loop.

Authors:  Youhna M Ayala; Laura De Conti; S Eréndira Avendaño-Vázquez; Ashish Dhir; Maurizio Romano; Andrea D'Ambrogio; James Tollervey; Jernej Ule; Marco Baralle; Emanuele Buratti; Francisco E Baralle
Journal:  EMBO J       Date:  2010-12-03       Impact factor: 11.598

9.  Structural insights into TDP-43 in nucleic-acid binding and domain interactions.

Authors:  Pan-Hsien Kuo; Lyudmila G Doudeva; Yi-Ting Wang; Che-Kun James Shen; Hanna S Yuan
Journal:  Nucleic Acids Res       Date:  2009-01-27       Impact factor: 16.971

10.  Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo.

Authors:  Andrea D'Ambrogio; Emanuele Buratti; Cristiana Stuani; Corrado Guarnaccia; Maurizio Romano; Youhna M Ayala; Francisco E Baralle
Journal:  Nucleic Acids Res       Date:  2009-05-08       Impact factor: 16.971

View more
  179 in total

Review 1.  The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches.

Authors:  Elisabeth Daguenet; Gwendal Dujardin; Juan Valcárcel
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

2.  Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology.

Authors:  Hyun-Sik Yang; Charles C White; Hans-Ulrich Klein; Lei Yu; Christopher Gaiteri; Yiyi Ma; Daniel Felsky; Sara Mostafavi; Vladislav A Petyuk; Reisa A Sperling; Nilüfer Ertekin-Taner; Julie A Schneider; David A Bennett; Philip L De Jager
Journal:  Neuron       Date:  2020-06-10       Impact factor: 17.173

Review 3.  Phenotypic Suppression of ALS/FTD-Associated Neurodegeneration Highlights Mechanisms of Dysfunction.

Authors:  Mathieu Bartoletti; Daryl A Bosco; Sandrine Da Cruz; Clotilde Lagier-Tourenne; Nicole Liachko; Sebastian Markmiller; Kristin M Webster; Kristi A Wharton
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

Review 4.  The Retrotransposon storm and the dangers of a Collyer's genome.

Authors:  Josh Dubnau
Journal:  Curr Opin Genet Dev       Date:  2018-05-08       Impact factor: 5.578

Review 5.  Relation Between Stress Granules and Cytoplasmic Protein Aggregates Linked to Neurodegenerative Diseases.

Authors:  Ioana Dobra; Serhii Pankivskyi; Anastasiia Samsonova; David Pastre; Loic Hamon
Journal:  Curr Neurol Neurosci Rep       Date:  2018-11-08       Impact factor: 5.081

Review 6.  Autophagy as a common pathway in amyotrophic lateral sclerosis.

Authors:  Dao K H Nguyen; Ravi Thombre; Jiou Wang
Journal:  Neurosci Lett       Date:  2018-04-04       Impact factor: 3.046

7.  Cryptic exon incorporation occurs in Alzheimer's brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43.

Authors:  Mingkuan Sun; William Bell; Katherine D LaClair; Jonathan P Ling; Heather Han; Yusuke Kageyama; Olga Pletnikova; Juan C Troncoso; Philip C Wong; Liam L Chen
Journal:  Acta Neuropathol       Date:  2017-03-22       Impact factor: 17.088

Review 8.  TDP43 and RNA instability in amyotrophic lateral sclerosis.

Authors:  Kaitlin Weskamp; Sami J Barmada
Journal:  Brain Res       Date:  2018-01-31       Impact factor: 3.252

9.  S-nitrosylated TDP-43 triggers aggregation, cell-to-cell spread, and neurotoxicity in hiPSCs and in vivo models of ALS/FTD.

Authors:  Elaine Pirie; Chang-Ki Oh; Xu Zhang; Xuemei Han; Piotr Cieplak; Henry R Scott; Amanda K Deal; Swagata Ghatak; Fernando J Martinez; Gene W Yeo; John R Yates; Tomohiro Nakamura; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

Review 10.  Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.

Authors:  Vittoria Pagliarini; Piergiorgio La Rosa; Claudio Sette
Journal:  Hum Genet       Date:  2017-04-22       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.